Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Blomqvist

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Cancer Treatment Reviews|June 22, 2001
Assessment of response to systemic therapy focusing on metastatic bone diseaseC Blomqvist
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1993
[Adjuvant chemotherapy of breast cancer]C Blomqvist
Medicine and Science in Sports and Exercise|October 1, 1996
Regulation of the systemic circulation at microgravity and during readaptation to 1GG C Blomqvist
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Clodronate and other bisphosphonates as supportive therapy in osteolysis due to malignancyI Elomaa, C Blomqvist
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Predictive factors for response to cytotoxic treatment in advanced breast cancer: a reviewJ Sjöström, C Blomqvist
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Bisphosphonate therapy in metastatic breast cancerC Blomqvist, I Elomaa
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2011
Trabectedin in the treatment of metastatic soft-tissue sarcoma: cost-effectiveness and cost-utility are yet to be provedC Blomqvist, R Johansson, M Tarkkanen
Breast Cancer Research and Treatment|January 1, 1986
Aminoglutethimide as second line therapy in advanced breast cancerI Elomaa, C Blomqvist, P Rissanen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: a randomized phase II trialI Elomaa, H Joensuu, C Blomqvist
Acta Oncologica (Stockholm, Sweden)|April 26, 2001
Effect of obesity on the leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface areaP Poikonen, C Blomqvist, H Joensuu
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Cancer Treatment Reviews|June 22, 2001
Assessment of response to systemic therapy focusing on metastatic bone diseaseC Blomqvist
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1993
[Adjuvant chemotherapy of breast cancer]C Blomqvist
Medicine and Science in Sports and Exercise|October 1, 1996
Regulation of the systemic circulation at microgravity and during readaptation to 1GG C Blomqvist
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Clodronate and other bisphosphonates as supportive therapy in osteolysis due to malignancyI Elomaa, C Blomqvist
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Predictive factors for response to cytotoxic treatment in advanced breast cancer: a reviewJ Sjöström, C Blomqvist
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Bisphosphonate therapy in metastatic breast cancerC Blomqvist, I Elomaa
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2011
Trabectedin in the treatment of metastatic soft-tissue sarcoma: cost-effectiveness and cost-utility are yet to be provedC Blomqvist, R Johansson, M Tarkkanen
Breast Cancer Research and Treatment|January 1, 1986
Aminoglutethimide as second line therapy in advanced breast cancerI Elomaa, C Blomqvist, P Rissanen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: a randomized phase II trialI Elomaa, H Joensuu, C Blomqvist
Acta Oncologica (Stockholm, Sweden)|April 26, 2001
Effect of obesity on the leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface areaP Poikonen, C Blomqvist, H Joensuu
Pageof 15